Job Post: Global Patient Safety Medical Advisor

Job Post: Global Patient Safety (GPS) Medical Fellow/Advisor

Responsibilities

The purpose of the GPS Medical Fellow/Senior Medical Advisor/ Medical Advisor is to perform medical roles within the Global Patient Safety (GPS) Medical function. These include performing as the Product or Molecule Safety Lead Physician, demonstrating Global Patient Safety expertise and coaching. He or she is the Eli Lilly & Co. GPS Medical Area representative for both internal and external customers regarding a product or molecule, interacting as prescribed in corporate guidelines, standards and policies. Individualized responsibilities for a particular product or project will be discussed and agreed at an individual level.

Key Responsibilities

1. Product or Molecule Safety Physician / Lead Physician

• Provide global medical leadership and input into all aspects of safety of assigned product(s) including surveillance programs and risk management planning.
• Ensure proactive safety surveillance
o i. lead risk management activities for assigned products globally
• ii. lead and guide the surveillance activities of scientists on the team including signal detection and clarification activities and risk evaluation activities; provide support, training and continued improvement as appropriate
• iii. manage decisions and actions to be taken, including communication to appropriate customers (e.g., Product Teams, Management, Affiliates and Regulators) and
• iv. liaise with GPS Medical Area Directors and with Lilly Medical Therapeutic Area Team Leaders and Directors, as appropriate, to fulfill safety obligations;
• Supervise and review reports on safety issues and their implications for the Core Safety Information and Core Risk Minimization Activities, represent PV position to Global Patient Labeling Committee and/or the Safety Review Committee as appropriate.
• Build collaborative working relationships with other Global Patient Safety Physicians and development and brand teams medical globally to ensure full cooperation and high quality medical evaluation of safety data for global regulatory purposes.
o i. Represent GPS Medical and/or Product on appropriate committees/product development and brand teams.
• ii. Provide medical support for Global Patient Safety activities and reports within the department, as appropriate.
• iii. Provide Global Patient Safety expertise to internal customers (e.g., regulatory, early phase development, business units).
• iv. Provide medical input for review of Adverse Event cases.
• v. Lead process and provide medical input for review of Suspected Adverse Reactions
• Demonstrate knowledge in pharmacovigilance and risk minimization, which includes understanding of relevant aspects of laws, regulations and guidance.

Job Post: Oncology Clinical Research Physician

Job Post: Oncology Clinical Research Physician

Responsibilities

The Oncology Clinical Research Physician (CRP) will combine scientific and clinical expertise with his/her passion for helping cancer patients to make meaningful differences to the lives of many people. He/she helps create solutions for patients, health care professionals, and caregivers that have broad impact across the world.

He/She participates in the development, conduct and reporting of local clinical trials; the implementation of global clinical trials ; the reporting of adverse events as mandated by corporate patient safety; review process for protocols, study reports, publications and data dissemination for products; medical outreach, and various medical activities in support of demand realization.

The CRP is an integral member of the Oncology brand team for strategic planning in the support of launch and commercialization activity and may work with Development team(s), Therapeutic Area Program Phase, Early Phase /Exploratory Program Medicine (EPM), and Translational Medicine team(s) in new product development activities over the entire spectrum of drug development and clinical trial phases.

Core Job Responsibilities

The primary responsibilities of the Oncology Medical Affairs CRP are generally related to late-phase and marketed compounds. The CRP is responsible for collaborating with local research staff in the planning, startup and conduct of phase 3b/4 studies. The core job responsibilities include those listed below as well as all other duties as assigned.

BioSpace Pharm Country Career Fair

Looking for a job in the biotech or pharmaceutical industry? How about with a contract research organization or CRO?

BioSpace Pharm Country Career Fair
Radisson Valley Forge
Tuesday, May 21, 2013
11am - 4pm

Learn more here.

BIO Career Fair at the 2013 BIO Convention

The BIO Career Fair will be held on Monday, April 22, in conjunction with the 2013 BIO International Convention in Chicago.

BIO Career Fair
Monday, April 22, 2013
Hyatt Regency Chicago
151 E. Wacker Drive

More information can be found here: http://www.biocareerfair.org

2013 BIO International Convention, April 22-25, 2013

Don't miss the 2013 BIO International Convention, April 22-25, 2013
Chicago, IL

This is where science meets business—16,500 attendees from 65 countries, 4 football fields of exhibits, 125+ sessions across 17 topic areas, and biotech’s largest partnering event.

Learn more about this event here:  http://convention.bio.org/

BioPharma Asia Convention 2013

Looking for an excuse to visit Asia? How about Singapore?

BioPharma Asia Convention 2013 is the largest and most strategic event in Asia that brings together more than 4,000 key stakeholders and decision makers from all across the globe to explore partnership ideas, business trends and investment opportunities in Asia's biopharma sector.

March 18-21
Singapore

Learn more about this conference here.

Medical Director jobs in pharma and biotech

Hiring tends to slow down over the holidays, but a number of pharmaceutical and biotechnology companies look to be hiring medical directors. Take a look at some of those pharma and biotech medical director jobs here.

MM&M 2012 Career & Salary Survey

Every year, Medical Marketing & Media conducts a salary survey among executives working in the pharmaceutical industry. The 26th MM&M Career & Salary Survey reports average salaries are slightly outpacing inflation, up 2.8% to 132.6K and just below 2007's high of 133.7K.

According to their survey, Medical Directors have an average salary of $176,700 which is up 7.1%. With an n=17 medical directors, this is a relatively small sample.

The online survey was emailed to more than 40,000 executives employed in pharmaceuticals, healthcare marketing and related fields, encompassing manufacturers, agencies, media companies and service suppliers/vendors, during August and September.

Of the 994 qualified respondents: 403 are employed by manufacturers (pharma, biotech, devices, diagnostics), 345 by agencies, 77 work in healthcare media and 88 for suppliers/vendors; 524 are male and 470 are female; and the average age is 43 years.

You can read about the survey here and access the complete report here (PDF).

Medical director jobs in pharmaceutical companies

Interested in a job in pharma? There are many medical director, VP of medical affairs, and to some extent even chief medical officer jobs out there that you can find. You can find these jobs listings by searching here. You'll find jobs posted by small to big pharma and biotech companies.

Find a variety of non-clinical jobs on our Job Board.

Synergy Pharmaceuticals Appoints Gail M. Comer, M.D. as Chief Medical Officer

NEW YORK, May 2, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP) (Nasdaq:SGYPU) (Nasdaq:SGYPW), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the appointment of Gail M. Comer, M. D. as Chief Medical Officer, effective May 14, 2012. In this newly created position, Dr. Comer will report directly to President and Chief Executive Officer, Gary S. Jacob, Ph.D., and will be responsible for guiding Synergy's clinical programs, including the ongoing Phase II/III study of plecanatide, the Company's leading drug candidate.

Dr. Gail Comer, a board-certified gastroenterologist and hepatologist, has more than 14 years of experience in the pharmaceutical industry, having spent 7 years at Abbott Laboratories as a Medical Director, six years in clinical development at Wyeth Research as Senior Medical Director, and most recently as Senior Director of the BioTherapeutics Research Unit at Pfizer. While at Wyeth, Dr. Comer was Medical Research Leader in Gastroenterology, and more recently, while at Pfizer, was Clinical Lead for multiple biologic compounds in early development in inflammatory bowel disease.

Pharma Thursdays

Pharma Thursdays is a networking group that meets monthly. It grew out of the need for a group in the life science community where people of every level, regardless of company affiliation could get together to exchange ideas, interact, learn and network.

In September of 2008, group founder Ted Gilbert and several other life science professionals saw the need for networking events where people working in all levels of life sciences could get together in Philadelphia. The idea was to gather once a month and exchange ideas, talk about what was going on in the local industry and collect perspectives from people that work in the same industry but carry different skill sets.

They now have over 1,000 members. Chapters are in Princeton, New York City and South Florida. I'm sure we'll see other chapters as well.

Learn more about Pharma Thursdays here.

44% of pharma employees are worried about losing their jobs

This is a direct quote from a recent Medical Media & Marketing story titled, "Pharma fears additional job fallout."

Though the broader economy is showing signs of picking up, a survey of drug company execs suggests that the era of pink slips continues to bedevil the pharma industry. PharmaIQ's "The Big Pharma Recession Report” found that 44% of pharma employees are worried about losing their jobs.


The study highlights additional support for the less-is-more strategy: 60% of employees who were working in downsized departments said the same amount of work was being done by fewer people.

So, what does all this mean and what will the biopharmaceutical industry look like in 5 or 10 years when so many essential medications are available as generics? What will happen when bioequivalents enter the market?

Leadership and Strategy in Pharmaceuticals and Biotech

"Leadership and Strategy in Pharmaceuticals and Biotech" is an executive program offered by Harvard Business School this spring. Here is some additional information regarding this program:

Revolutions in technology, markets, and government policy are transforming the playing field for pharmaceutical and biotechnology companies. This program prepares high-potential executives to become better managers and leaders—and lays a foundation for strategically positioning their companies for a world of change.

What You Can Expect
Created to enhance individual leadership capacity and boost corporate performance, this leadership development program enables participants to evaluate alternative business models, competitive strategies, and financial approaches, as well as explore issues ranging from profitability, organizational change, and intellectual property to global distribution.

SJU/HBS Roundtable: Pharmaceutical Sustainability

Tonight, Saint Joseph’s University/ Harvard Business School Health Industry Alumni Association is holding a roundtable discussion titled, "Why are People Still the Most Important Asset for a Pharmaceutical Firm’s Sustainability?"

Scan nearly any pharmaceutical company's annual report for the past five years and three strategic themes are usually conveyed: transformation of current operations, growth in emerging markets, and innovation for new products/services. While processes and systems are factors in supporting these remits, a firm's purposely-engaged staff is the critical element that ultimately drives long-term sustainability. To hear the latest insights on how a few firms are tapping into innovative human-capital management ideas, join us on October 27, 2011 at Saint Joseph's University, located at the corner of City Avenue and N. 54th Street in Philadelphia,

Learn more here.

Amgen laying off about 380 R&D workers

According to this story on the Los Angeles Times, Amgen is cutting jobs in research and development (R&D).

The layoffs represent about 6% of Amgen's total 6,700 workers in research and development. Amgen employs about 17,600 workers globally.

A number of years ago, physicians and scientists who worked in R&D had a level of job security that pales in comparison to today. Changes in the global economy along with regulatory challenges in drug development have led to cuts in R&D in many biopharmaceutical companies.

BioConference Live Fall: Life Sciences

Here's a free online conference called BioConference Live Fall: Life Sciences
October 26-27, 2011

Hear from physicians working in the biopharmaceutical industry about some of their research and their work.

The theme of this free virtual conference is Drug Discovery, Cancer Research, and Genetics & Genomics. This event will bring together research scientists, post docs, principal investigators, lab directors and professionals from around the world to learn about recent advances in life sciences. BioConference Live offers an amazing opportunity as it is free to participants, there is no out-of-pocket expenses for travel, and all available from the comfort of your office or home.

BioMidwest Career Fair

If you live in the Chicago area, you won't want to miss this event:

BioMidwest Career Fair
Chicago Marriott Oak Brook
Tuesday, October 4, 2011
11am to 4pm

Attend the BioMidwest Career Fair!
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Midwest region.

What types of positions are available?
Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Exhibitors who have jobs posted on BioSpace.com have their company name linked to their job postings in the list below. We highly recommend researching open positions before you attend the event. It will help you determine which companies are a good match and make you look more prepared and knowledgeable when approaching recruiters.

Pharmaceutical industry leading job cuts: "Job Cuts Surge 60% to 16-Month High"

Do you think the recession is ending, or are we seeing a second dip? According to a recent report released by Challenger, Gray & Christmas, Inc., the pharmaceutical industry is leading all the other industries in job cuts:

The pharmaceutical led all other industries with 13,493 job cuts in July, most of which (13,000 to be exact) resulted from a multi-year reduction in force announced by New York-based Merck & Co.

The 66,414 job cuts last month were up 60 percent from the previous month, when employers announced plans to shed 41,432 workers. The July figure was 59 percent higher than the 41,676 layoffs recorded in July 2010. It was the largest monthly total since March 2010, when 67,611 job cuts were announced by the nation’s employers.

You can read their report here (PDF)

Drug Development Boot Camp at Harvard University

Drug Development Skills are Difficult to Acquire

DRUG DEVELOPMENT BOOT CAMP
NOVEMBER 9-10, 2011
THE HARVARD CLUB • BOSTON, MA

The pharmaceutical industry has its fair share of Ph.D.s, and MDs, and yet qualifications do not translate into understanding of the drug development process. In fact, Nobel Laureate scientists find the drug development process bewildering.

As drug development costs increase, the process of drug development is becoming more and more complex. Those involved with the process of developing new therapeutics (drugs, devices, combination products and diagnostics) must understand the process and be able to navigate it with great skill. These skills are difficult to acquire.

Considering a "pharmaceutical MBA?"

If you search for "pharmaceutical MBA" in Google, you'll find that the first page of search results lists the following MBA programs that focus on the pharmaceutical industry:

• Executive Pharmaceutical & Healthcare Marketing MBA from Saint Joseph's University
• MBA in Pharmaceutical Management from Drexel University
• MBA in Pharmaceutical Management from Fairleigh Dickinson University
• MBA in Pharmaceutical Management from Rutgers Business School

The University of the Sciences in Philadelphia offers an MBA in Pharmaceutical and Healthcare Business. The University of Colorado offers an Executive MBA in Pharmaceutical Management. Aspen University offers an MBA in Pharmaceutical Marketing and Management.